BIOMAT Database Logo BIOMAT Database Logo

Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease. 2007

M M Harmsen, and C B van Solt, and H P D Fijten, and L van Keulen, and R A Rosalia, and K Weerdmeester, and A H M Cornelissen, and M G M De Bruin, and P L Eblé, and A Dekker
Animal Sciences Group of Wageningen University and Research Centre, 8200 AB Lelystad, The Netherlands. michiel.harmsen@wur.nl

Foot-and-mouth disease (FMD) is a highly contagious disease that occasionally causes outbreaks in Europe. There is a need for therapies that provide rapid protection against FMD in outbreak situations. We aim to provide such rapid protection by passive immunization with llama single-domain antibody fragments (VHHs). Twenty-four VHHs binding serotype O FMDV in vitro were isolated from immunized llamas by phage display and expressed in bakers yeast for further characterization. They recognized four functionally independent antigenic sites. Six strongly FMDV neutralizing VHHs bound to a peptide representing the GH-loop of viral protein 1 known to be involved in binding to the cellular receptor of FMDV. Clone M8, recognizing this antigenic site, and clone M23, recognizing another antigenic site, showed synergistic in vitro virus neutralization. Three FMDV specific VHHs were PEGylated in order to decrease their rapid blood clearance and thus enable in vivo guinea pig protection experiments. Passive immunization with individual VHHs showed no protection, but a mixture of M8 and M23 showed partial transient protection. The protection afforded by these VHHs was however low as compared to the complete protection afforded by convalescent guinea pig serum. In contrast, these VHHs showed far more efficient in vitro FMDV neutralization than convalescent guinea pig serum. This lack of correlation between in vitro neutralization and in vivo protection lends further credence to the notion that opsonophagocytosis of FMDV is important for protection in vivo.

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007128 Immunoglobulin Fragments Partial immunoglobulin molecules resulting from selective cleavage by proteolytic enzymes or generated through PROTEIN ENGINEERING techniques. Antibody Fragment,Antibody Fragments,Ig Fragment,Ig Fragments,Immunoglobulin Fragment,Fragment, Antibody,Fragment, Ig,Fragment, Immunoglobulin,Fragments, Antibody,Fragments, Ig,Fragments, Immunoglobulin
D007135 Immunoglobulin Variable Region That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions (COMPLEMENTARITY DETERMINING REGIONS) and framework regions. Variable Region, Ig,Variable Region, Immunoglobulin,Framework Region, Immunoglobulin,Fv Antibody Fragments,Fv Fragments,Ig Framework Region,Ig Variable Region,Immunoglobulin Framework Region,Immunoglobulin Fv Fragments,Immunoglobulin V,Antibody Fragment, Fv,Antibody Fragments, Fv,Fragment, Fv,Fragment, Fv Antibody,Fragment, Immunoglobulin Fv,Fragments, Fv,Fragments, Fv Antibody,Fragments, Immunoglobulin Fv,Framework Region, Ig,Framework Regions, Ig,Framework Regions, Immunoglobulin,Fv Antibody Fragment,Fv Fragment,Fv Fragment, Immunoglobulin,Fv Fragments, Immunoglobulin,Ig Framework Regions,Ig Variable Regions,Immunoglobulin Framework Regions,Immunoglobulin Fv Fragment,Immunoglobulin Variable Regions,Regions, Immunoglobulin Variable,Variable Regions, Ig,Variable Regions, Immunoglobulin
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D010802 Phylogeny The relationships of groups of organisms as reflected by their genetic makeup. Community Phylogenetics,Molecular Phylogenetics,Phylogenetic Analyses,Phylogenetic Analysis,Phylogenetic Clustering,Phylogenetic Comparative Analysis,Phylogenetic Comparative Methods,Phylogenetic Distance,Phylogenetic Generalized Least Squares,Phylogenetic Groups,Phylogenetic Incongruence,Phylogenetic Inference,Phylogenetic Networks,Phylogenetic Reconstruction,Phylogenetic Relatedness,Phylogenetic Relationships,Phylogenetic Signal,Phylogenetic Structure,Phylogenetic Tree,Phylogenetic Trees,Phylogenomics,Analyse, Phylogenetic,Analysis, Phylogenetic,Analysis, Phylogenetic Comparative,Clustering, Phylogenetic,Community Phylogenetic,Comparative Analysis, Phylogenetic,Comparative Method, Phylogenetic,Distance, Phylogenetic,Group, Phylogenetic,Incongruence, Phylogenetic,Inference, Phylogenetic,Method, Phylogenetic Comparative,Molecular Phylogenetic,Network, Phylogenetic,Phylogenetic Analyse,Phylogenetic Clusterings,Phylogenetic Comparative Analyses,Phylogenetic Comparative Method,Phylogenetic Distances,Phylogenetic Group,Phylogenetic Incongruences,Phylogenetic Inferences,Phylogenetic Network,Phylogenetic Reconstructions,Phylogenetic Relatednesses,Phylogenetic Relationship,Phylogenetic Signals,Phylogenetic Structures,Phylogenetic, Community,Phylogenetic, Molecular,Phylogenies,Phylogenomic,Reconstruction, Phylogenetic,Relatedness, Phylogenetic,Relationship, Phylogenetic,Signal, Phylogenetic,Structure, Phylogenetic,Tree, Phylogenetic
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002161 Camelids, New World Camelidae of the Americas. The extant species are those originating from South America and include alpacas, llamas, guanicos, and vicunas. Alpacas,Guanacos,Llamas,Lama glama,Lama glama guanicoe,Lama guanicoe,Lama pacos,Vicugna pacos,Vicugna vicugna,Vicunas,Alpaca,Camelid, New World,Guanaco,Llama,New World Camelid,New World Camelids,Vicuna
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked

Related Publications

M M Harmsen, and C B van Solt, and H P D Fijten, and L van Keulen, and R A Rosalia, and K Weerdmeester, and A H M Cornelissen, and M G M De Bruin, and P L Eblé, and A Dekker
Passive immunization with llama single-domain antibody fragments reduces foot-and-mouth disease transmission between pigs.
March 2009, Vaccine,
M M Harmsen, and C B van Solt, and H P D Fijten, and L van Keulen, and R A Rosalia, and K Weerdmeester, and A H M Cornelissen, and M G M De Bruin, and P L Eblé, and A Dekker
Passive immunization of pigs with bispecific llama single-domain antibody fragments against foot-and-mouth disease and porcine immunoglobulin.
November 2008, Veterinary microbiology,
M M Harmsen, and C B van Solt, and H P D Fijten, and L van Keulen, and R A Rosalia, and K Weerdmeester, and A H M Cornelissen, and M G M De Bruin, and P L Eblé, and A Dekker
Experiments on active immunization of pigs against foot-and-mouth disease.
January 1971, Acta veterinaria Academiae Scientiarum Hungaricae,
M M Harmsen, and C B van Solt, and H P D Fijten, and L van Keulen, and R A Rosalia, and K Weerdmeester, and A H M Cornelissen, and M G M De Bruin, and P L Eblé, and A Dekker
[The role of passive immunization of piglets against foot-and-mouth disease].
September 1974, Veterinariia,
M M Harmsen, and C B van Solt, and H P D Fijten, and L van Keulen, and R A Rosalia, and K Weerdmeester, and A H M Cornelissen, and M G M De Bruin, and P L Eblé, and A Dekker
Immunization of guinea pigs with foot-and-mouth disease virus subjected to photodynamic inactivation.
January 1966, Acta pathologica et microbiologica Scandinavica,
M M Harmsen, and C B van Solt, and H P D Fijten, and L van Keulen, and R A Rosalia, and K Weerdmeester, and A H M Cornelissen, and M G M De Bruin, and P L Eblé, and A Dekker
Protection of guinea-pigs against foot-and-mouth disease virus by immunization with a PhoE-FMDV hybrid protein.
October 1990, Vaccine,
M M Harmsen, and C B van Solt, and H P D Fijten, and L van Keulen, and R A Rosalia, and K Weerdmeester, and A H M Cornelissen, and M G M De Bruin, and P L Eblé, and A Dekker
Efficacy of foot-and-mouth disease vaccine in pigs with single dose immunization.
May 2003, Vaccine,
M M Harmsen, and C B van Solt, and H P D Fijten, and L van Keulen, and R A Rosalia, and K Weerdmeester, and A H M Cornelissen, and M G M De Bruin, and P L Eblé, and A Dekker
[Practical experiences in the immunization of pigs against foot-and-mouth disease].
January 1963, Deutsche tierarztliche Wochenschrift,
M M Harmsen, and C B van Solt, and H P D Fijten, and L van Keulen, and R A Rosalia, and K Weerdmeester, and A H M Cornelissen, and M G M De Bruin, and P L Eblé, and A Dekker
[Immunization of pigs against foot-and-mouth disease with tissue culture virus--saponin vaccine].
September 1963, Deutsche tierarztliche Wochenschrift,
M M Harmsen, and C B van Solt, and H P D Fijten, and L van Keulen, and R A Rosalia, and K Weerdmeester, and A H M Cornelissen, and M G M De Bruin, and P L Eblé, and A Dekker
Llama DNA Immunization and Isolation of Functional Single-Domain Antibody Binders.
January 2022, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!